Unknown PHASE1 INTERVENTIONAL 1-arm NCT00563537

Molecular Imaging Modality by Positron Emission Tomography Using 18F-X : Study of Microglial Activation in Amyotrophic Lateral Sclerosis

Sponsor: University Hospital, Tours

Conditions Amyotrophic Lateral Sclerosis Bulbar Disease Spinal Disease

Updated 5 times since 2017 Last updated: Mar 18, 2010 Started: Jan 31, 2007 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00563537, this PHASE1 trial focuses on Amyotrophic Lateral Sclerosis and Bulbar Disease and remains ongoing. Sponsored by University Hospital, Tours, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Tours

Data source: University Hospital, Tours

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tours, France